A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...

The typical treatment for estrogen receptor positive (ER+) breast cancer involves surgery and years of hormone therapy that ...

A study by DKFZ researchers shows that inhibiting the enzyme aldolase A in glycolysis traps energy in liver cancer cells, ...

Researchers at the Crick have uncovered which genes on the Y chromosome regulate the development of sperm and impact ...

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...

Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.

According to the World Health Organization (WHO), in 2022, there were 2.3 million women diagnosed with breast cancer and 670 ...

Glycolysis is an important sugar degradation pathway that cancer cells in particular depend on. Scientists at the German Cancer Research Center (DKFZ) have now shown that liver cancer cells in mice ...

Salk scientists discover protein first identified at Salk in 1996 called PIN1 encourages tumor growth in bladder cancer, then ...

Effectively killed multiple human ER+ breast cancer cell lines in culture. Was well tolerated, with no obvious deleterious effects, by multiple species (mice, rats and beagles). Shrank ...